Affiliations 

  • 1 Yale University AIDS Program, Yale School of Medicine, New Haven, CT, USA. kelsey.loeliger@yale.edu
  • 2 Department of Biostatistics, University of Washington, Seattle, WA, USA
  • 3 Department of Global Community Health and Behavioral Sciences, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA
  • 4 Department of Medicine/Infectious Diseases, The Miriam Hospital/Alpert Medical School of Brown University, Providence, RI, USA
  • 5 Department of Epidemiology and Biostatistics, George Washington University Milken Institute School of Public Health, Washington, DC, USA
  • 6 Friends Research Institute Inc., Baltimore, MD, USA
  • 7 Yale University AIDS Program, Yale School of Medicine, New Haven, CT, USA
  • 8 Department of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, USA
  • 9 Division of General Internal Medicine and Health Services Research, Department of Medicine, Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
  • 10 Division of Infectious Diseases, Immunology and International Medicine, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
AIDS Behav, 2017 Oct;21(10):2945-2957.
PMID: 28188460 DOI: 10.1007/s10461-017-1722-9

Abstract

The U.S. female criminal justice (CJ) population is rapidly growing, yet large-scale studies exploring gender-specific HIV risk behaviors in the CJ population are lacking. This analysis uses baseline data on adults with a CJ history from eight U.S. studies in an NIH-funded "Seek, Test, Treat, Retain" harmonization consortium. Data were collected using a standardized HIV risk behavior assessment tool and pooled across studies to describe participants' characteristics and risk behaviors. Multilevel mixed-effects logistic regression models were used to test for gender-based behavior differences. Among 784 HIV-positive (21.4% female) and 5521 HIV-negative (8.5% female) participants, HIV-positive women had higher odds than HIV-positive men of engaging in condomless sexual intercourse (AOR 1.84 [1.16-2.95]) with potentially sero-discordant partners (AOR 2.40 [1.41-4.09]) and of sharing injection equipment (AOR 3.36 [1.31-8.63]). HIV risk reduction interventions targeting CJ-involved women with HIV are urgently needed as this population may represent an under-recognized potential source of HIV transmission.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.